Bisciotti invests $100M in world-changing technologies
Baltimore Ravens owner Steve Bisciotti invested $100 million to help bring what's being called world-changing technologies to life.
Source: wbaltv.com
Phil Robilotto News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phil Robilotto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phil Robilotto Today - Breaking & Trending Today
GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline
/PRNewswire/ -- GEn1E Lifesciences, a next-generation multitarget techbio company developing novel and targeted immunomodulators, has secured an exclusive,...
Source: prnewswire.com
GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline
GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Published Study Results Demonstrate Substantial Length of Stay and Hospital Cost Reductions with Use of CoapTech's PUMA-G System™ for Gastrostomy When Compared to Usual Care Methods
/PRNewswire/ -- CoapTech, Inc, a medical device company focused on delivering transformative solutions for minimally-invasive surgery, announced today...
Source: prnewswire.com
University of Maryland, Baltimore (UMB) Grants GlycoMantra Exclusive License to Advance the Company's Therapeutic Pipeline · BioBuzz
GlycoMantra, a University of Maryland, Baltimore (UMB) startup company developing therapeutics for unmet medical needs in prostate cancer, NASH liver fibrosis, and type 2 diabetes, has been granted worldwide, exclusive rights to a UMB technology to advance the company's pipeline of therapeutics for treating drug-resistant metastatic colorectal cancer (mCRC).
Source: biobuzz.io